Background and Culture, University Hospitals

Founded in 1866 as the original Lakeside Hospital, University Hospitals (UH) has grown to serve the needs of patients throughout Ohio with an integrated network of 18 hospitals and more than 50 outpatient health centers in 15 counties, employing more than 2,000 physicians and 26,000 staff, and educating more than 1100 physicians and thousands of nurses and affiliated healthcare providers each year. At the core of its $4.5 billion enterprise health system is UH Cleveland Medical Center, ranked among America’s50 best hospitals by U.S. News & World Report in 10 methodology-ranked specialties and designated as a Magnet© recognized facility.

Neuro-Oncology at the University Hospitals Neurological Institute

The Neurological Institute is one of 9 clinical-care-delivery institutes at University Hospitals Health System and is dedicated to providing specialized care throughout the health system, bringing faculty from Neurology and Neurosurgery together with Psychiatry, Physical Medicine and Rehabilitation, Neuroradiology, and Neuropathology into designated centers of excellence.

Neurology was first created as a division of Medicine in 1961 and under its first chair, Joseph M Foley MD, soon became known as the training ground for future chairs and national society leaders, recruiting the husband-and- wife team of Maurice Victor, Betty Banker, Stanley van den Noort and Simon Horenstein. Although Foley’s scholarly work focused on cerebrovascular anatomy, he became known for his empathetic care of elderly patients with dementia, for which the Foley Elder Health Center was named. In 1980, Neurology became a department under Robert B Daroff MD from 1980-1995 and 2006-2008, and was known for scientific writing and editing and leadership of one of the longest NIH-funded laboratories, the Daroff-Dell’Osso Ocular Motility Laboratory at the Cleveland VA Medical Center. In 2006, the Neurological Institute was one of the first in the country to combine the Departments of Neurology and Neurosurgery, and under Anthony J Furlan MD, from 2008-2019, the patient-centric divisions and centers grew along with the tremendous growth of the UH health system. In 2019, Cathy Sila MD assumed the chair with the goal to reproduce the stroke center’s accomplishments in system integration and data- driven operational innovation to high-value care and “systemness.”

The current department of Neurology has 65 active faculty, including 41% women, 8% Asian, and 8% underrepresented minority Hispanic/African-American. The divisions (centers) and programs include Brain Health and Memory, Brain Tumor and Neuro-Oncology, Community Neurology, Comprehensive Stroke, Epilepsy, Headache, Neurocritical Care, Neuromuscular Disorders, Neuro-Ophthalmology, Neuropsychology, Parkinson’s & Movement Disorders, Multiple Sclerosis & Neuroimmunology, Music & Medicine, and Sleep.

Brain Tumor and Neuro-Oncology Center of Excellence, Neurological Institute

The Brain Tumor and Neuro-Oncology Center is one of the first designated Centers of Excellence at University Hospitals with over $9M total NIH and industry funding. The IRB-approved Brain Tumor Biorepository includes tumor and blood samples with clinical outcome data in ~3550 patients. Clinical Research partnerships include:

• Adult Brain Tumor Consortium (ABTC) Brain Tumor Center of Excellence- as one of 11 sites designated by the National Cancer Institute sites in the US, the Case Comprehensive Cancer Center offers new drug and treatment approaches and early phase clinical trials, incorporating pharmacology and novel imaging biomarkers.
• NRG Oncology Group- as the #2 top accruing Lead Academic Participating site in 2020 in the National Clinical Trials Network, offering practice-changing, multi-institutional clinical and translational research.
• The Cancer Genome Atlas Glioblastoma Multiforme (TGCA-GBM)- as one of 8 contributors, focusing on connecting cancer phenotypes to genotypes by connecting images from the Cancer Genome Atlas to clinical, genetic, and pathologic data.
• Other affiliations include the Glass Consortium- as a contributing member in molecular characterization of high- quality tumor samples, the Central Brain Tumor Registry of the US (CBTRUS) and the Ohio Brain Tumor Study.

The Brain Tumor and Neuro-Oncology Center in the Neurological Institute at University Hospitals and partners in the UH Seidman Cancer to provide a multidisciplinary team approach to customize treatment plans based on the patient’s personal goals. Serving patients locally, regionally, nationally and internationally, the center offers the next generation of medical and surgical innovations with priority patient access and a high-value care model including a Cellular Therapy Program, Gamma Knife Program, Cyber Knife Program and Proton Beam Program.

The center neurologists are core faculty in the ACGME accredited Neurology Residency of University Hospitals- Case Western Reserve University School of Medicine- the 2nd largest in the US- with 12 positions per year, including an Education Track and a Research Track.

Purpose of the Position

The Neurological Institute at University Hospitals seeks to grow its Brain Tumor & Neuro-Oncology Center and is seeking either a neurologist or oncologist having completed a fellowship or equivalent training in neuro-oncology. This is an extraordinary opportunity to advance high value care across a clinical enterprise at a leading academic health system.

The Neurological Institute is a national leader in Neuro-Oncology and is heavily vested in further expansion. Members of the Neuro-Oncology Center interact directly with clinicians and researchers of the University Hospitals Seidman Cancer Center. Located on the campus of Case Western Reserve University, Cleveland, Ohio, University Hospitals Seidman Cancer Center is a member of the NCI-designated Case Comprehensive Cancer Center.

The Neuro-Oncology Program is a clinical and academic program with a world renowned faculty that is particularly well known in the fields of surgical and medical clinical trials for CNS tumors, immunotherapy, and cancer stem cells. Staff members have leadership roles in the NCI-sponsored consortia including ABTC and NRG. Neuro-Oncology staff hold academic positions at Case Western Reserve University (CWRU) and have close links with CWRU Neurosciences, the School of Medicine and CWRU Biomedical Engineering where the Center collaborates on a number of projects.

Key Responsibilities

Responsibilities of the position include active participation in the clinical, educational and research programs of the Neuro-Oncology Center. An academic career orientation is strongly encouraged. Early career mentorship will be provided wherever appropriate.

Faculty appointments at Case Western Reserve University will be at any level, commensurate with experience and credentials. Neuro-oncology faculty will have dual appointments in both the Department of Neurology and Oncology. Leadership opportunities available for qualified candidates.

The Candidate

Experience and Professional Qualifications

Candidates must possess M.D., D.O. or M.D./Ph.D. degrees as well as ability to obtain an unrestricted medical license in the state of Ohio is also required.

The ideal candidate should be board certified/board eligible in Neurology or Oncology and should have at least one year fellowship training in a UCNS-accredited Neuro-Oncology program.

Skills and Competencies

• A minimum of 3-5 years of experience in the evaluation and management of patients with primary and metastatic neoplasm and neurological complications of cancer is preferred. Potential leadership titles available for qualified candidates.

Education

• M.D., D.O. or M.D./Ph.D. degrees as well as ability to obtain an unrestricted medical license in the state of Ohio is also required.

Compensation

• Competitive compensation, dependent upon experience

SE# 510603630